Immunofluorescence Antibody Validation Report for Anti-NFκB-p105/p50 Antibody...St John's Laboratory Ltd
NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity.
Anti-NFκB-p105/p50 -http://www.stjohnslabs.com/nfkb-p105p50-antibody
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Transcriptional regulator which can act both as a coactivator and a corepressor and is the critical downstream regulatory target in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis . The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ . Plays a key role in tissue tension and 3D tissue shape by regulating cortical actomyosin network formation. Acts via ARHGAP18, a Rho GTPase activating protein that suppresses F-actin polymerization . Plays a key role to control cell proliferation in response to cell contact. Phosphorylation of YAP1 by LATS1/2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration . The presence of TEAD transcription factors are required for it to stimulate gene expression, cell growth, anchorage-independent growth, and epithelial mesenchymal transition (EMT) induction . / Isoform 2: Isoform 2 and isoform 3 can activate the C-terminal fragment (CTF) of ERBB4 (isoform 3).
Anti-YAP-http://www.stjohnslabs.com/yap-antibody-p-94815
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Immunofluorescence Antibody Validation Report for Anti-NFκB-p105/p50 Antibody...St John's Laboratory Ltd
NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity.
Anti-NFκB-p105/p50 -http://www.stjohnslabs.com/nfkb-p105p50-antibody
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Transcriptional regulator which can act both as a coactivator and a corepressor and is the critical downstream regulatory target in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis . The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ . Plays a key role in tissue tension and 3D tissue shape by regulating cortical actomyosin network formation. Acts via ARHGAP18, a Rho GTPase activating protein that suppresses F-actin polymerization . Plays a key role to control cell proliferation in response to cell contact. Phosphorylation of YAP1 by LATS1/2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration . The presence of TEAD transcription factors are required for it to stimulate gene expression, cell growth, anchorage-independent growth, and epithelial mesenchymal transition (EMT) induction . / Isoform 2: Isoform 2 and isoform 3 can activate the C-terminal fragment (CTF) of ERBB4 (isoform 3).
Anti-YAP-http://www.stjohnslabs.com/yap-antibody-p-94815
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Biological Buffers & Reagents are critical tools for every life sciences laboratory to get accurate and trusted results. Our Time-saving solutions are free of toxicity and have great stability, a very precise pH, and showing minimal salt-driven effects.
Canvax™ offers a wide range of Molecular Biology Grade solutions ideal for a wide range of common applications, like PBS, TBS, Tris-Glycine, EDTA, TE, TAE, TBE or Tris, with a DNAse, RNase or protease-free guarantee.
Involved in the activation cascade of caspases responsible for apoptosis execution. Binding of caspase-9 to Apaf-1 leads to activation of the protease which then cleaves and activates caspase-3. Promotes DNA damage-induced apoptosis in a ABL1/c-Abl-dependent manner. Proteolytically cleaves poly(ADP-ribose) polymerase (PARP). Isoform 2 lacks activity is an dominant-negative inhibitor of caspase-9. Strict requirement for an Asp residue at position P1 and with a marked preference for His at position P2. It has a preferred cleavage sequence of Leu-Gly-His-Asp-|-Xaa. Inhibited by the effector protein NleF that is produced by pathogenic E.coli; this inhibits apoptosis.
Anti-Caspase 9 -http://www.stjohnslabs.com/caspase-9-antibody-p-98614
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
CD5 is a cluster of differentiation expressed on the surface of T cells (various species) and in a subset of murine B cells known as B-1a. The expression of this receptor in human B cells has been a controversial topic and up to date there is no consensus regarding the role of this receptor as a marker of human B cells. B-1 cells have limited diversity of their B-cell receptor due to their lack of the enzyme terminal deoxynucleotidyl transferase (TdT) and are potentially self-reactive. CD5 serves to mitigate activating signals from the BCR so that the B-1 cells can only be activated by very strong stimuli (such as bacterial proteins) and not by normal tissue proteins. CD5 was used as a T-cell marker until monoclonal antibodies against CD3 were developed.
Anti-CD5 -http://www.stjohnslabs.com/cd5-antibody-p-98608
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Transcriptional regulator which can act both as a coactivator and a corepressor and is the critical downstream regulatory target in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis . The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ . Plays a key role in tissue tension and 3D tissue shape by regulating cortical actomyosin network formation.
Anti-YAP -http://www.stjohnslabs.com/yap-antibody-p-94815
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Growth factor that plays an essential role in the regulation of embryonic development, cell proliferation, cell migration, survival and chemotaxis. Potent mitogen for cells of mesenchymal origin . Required for normal proliferation and recruitment of pericytes and vascular smooth muscle cells in the central nervous system, skin, lung, heart and placenta. Required for normal blood vessel development, and for normal development of kidney glomeruli. Plays an important role in wound healing. Signaling is modulated by the formation of heterodimers with PDGFA.
Anti-PDGF-B -http://www.stjohnslabs.com/pdgf-b-antibody
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Microbial assays or microbiological assays could be a sort of bioassays designed to analyse the compounds or substances that have impact on micro-organisms. They help to estimate concentration and efficiency of antibiotics. Also facilitate in determination of the simplest anti-biotic appropriate for patient recovery.
Protein tyrosine kinase that is part of several cell surface receptor complexes, but that apparently needs a coreceptor for ligand binding. Essential component of a neuregulin-receptor complex, although neuregulins do not interact with it alone. GP30 is a potential ligand for this receptor. Regulates outgrowth and stabilization of peripheral microtubules (MTs). Upon ERBB2 activation, the MEMO1-RHOA-DIAPH1 signaling pathway elicits the phosphorylation and thus the inhibition of GSK3B at cell membrane. This prevents the phosphorylation of APC and CLASP2, allowing its association with the cell membrane. In turn, membrane-bound APC allows the localization of MACF1 to the cell membrane, which is required for microtubule capture and stabilization.
Anti-HER2 -http://www.stjohnslabs.com/her2-antibody-p-98582
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Receptor-regulated SMAD (R-SMAD) that is an intracellular signal transducer and transcriptional modulator activated by TGF-beta (transforming growth factor) and activin type 1 receptor kinases. Binds the TRE element in the promoter region of many genes that are regulated by TGF-beta and, on formation of the SMAD2/SMAD4 complex, activates transcription. May act as a tumor suppressor in colorectal carcinoma. Positively regulates PDPK1 kinase activity by stimulating its dissociation from the 14-3-3 protein YWHAQ which acts as a negative regulator.
Anti-Smad2 -http://www.stjohnslabs.com/smad2-antibody-p-94356
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Keratin 16 is a protein that in humans is encoded by the KRT16 gene.
Keratin 16 is a type I cytokeratin. It is paired with keratin 6 in a number of epithelial tissues, including nail bed, esophagus, tongue, and hair follicles. Mutations in the gene encoding this protein are associated with the genetic skin disorders pachyonychia congenita, non-epidermolytic palmoplantar keratoderma and unilateral palmoplantar verrucous nevus.
Anti-CK16 -http://www.stjohnslabs.com/ck16-antibody-p-98593
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Key regulator of entry into cell division that acts as a tumor suppressor. Promotes G0-G1 transition when phosphorylated by CDK3/cyclin-C. Acts as a transcription repressor of E2F1 target genes. The underphosphorylated, active form of RB1 interacts with E2F1 and represses its transcription activity, leading to cell cycle arrest. Directly involved in heterochromatin formation by maintaining overall chromatin structure and, in particular, that of constitutive heterochromatin by stabilizing histone methylation. Recruits and targets histone methyltransferases SUV39H1, KMT5B and KMT5C, leading to epigenetic transcriptional repression.
Anti-Rb -http://www.stjohnslabs.com/rb-antibody-p-94135
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Probably plays a role in facilitating the assembly of multimeric protein complexes inside the endoplasmic reticulum. Involved in the correct folding of proteins and degradation of misfolded proteins via its interaction with DNAJC10, probably to facilitate the release of DNAJC10 from its substrate
Anti-HSP A5 -http://www.stjohnslabs.com/hsp-a5-antibody
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Drug efflux transporter present in a number of stem cells that acts as a regulator of cellular differentiation. Able to mediate efflux from cells of the rhodamine dye and of the therapeutic drug doxorubicin. Specifically present in limbal stem cells, where it plays a key role in corneal development and repair.
Anti-ABCB5 -http://www.stjohnslabs.com/abcb5-antibody-p-98611
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Protein tyrosine kinase that is part of several cell surface receptor complexes, but that apparently needs a coreceptor for ligand binding. Essential component of a neuregulin-receptor complex, although neuregulins do not interact with it alone. GP30 is a potential ligand for this receptor. Regulates outgrowth and stabilization of peripheral microtubules (MTs). Upon ERBB2 activation, the MEMO1-RHOA-DIAPH1 signaling pathway elicits the phosphorylation and thus the inhibition of GSK3B at cell membrane. This prevents the phosphorylation of APC and CLASP2, allowing its association with the cell membrane. In turn, membrane-bound APC allows the localization of MACF1 to the cell membrane, which is required for microtubule capture and stabilization.
Anti-HER2 -http://www.stjohnslabs.com/her2-antibody-p-98582
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Tyrosine kinase of the non-receptor type, involved in the IFN-alpha/beta/gamma signal pathway . Kinase partner for the interleukin (IL)-2 receptor. ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.
Anti-JAK1 -http://www.stjohnslabs.com/jak1-antibody-p-92863
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation.
Anti-p70 S6 kinase α -http://www.stjohnslabs.com/p70-s6-kinase-a-antibody-p-93776
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Biological Buffers & Reagents are critical tools for every life sciences laboratory to get accurate and trusted results. Our Time-saving solutions are free of toxicity and have great stability, a very precise pH, and showing minimal salt-driven effects.
Canvax™ offers a wide range of Molecular Biology Grade solutions ideal for a wide range of common applications, like PBS, TBS, Tris-Glycine, EDTA, TE, TAE, TBE or Tris, with a DNAse, RNase or protease-free guarantee.
Involved in the activation cascade of caspases responsible for apoptosis execution. Binding of caspase-9 to Apaf-1 leads to activation of the protease which then cleaves and activates caspase-3. Promotes DNA damage-induced apoptosis in a ABL1/c-Abl-dependent manner. Proteolytically cleaves poly(ADP-ribose) polymerase (PARP). Isoform 2 lacks activity is an dominant-negative inhibitor of caspase-9. Strict requirement for an Asp residue at position P1 and with a marked preference for His at position P2. It has a preferred cleavage sequence of Leu-Gly-His-Asp-|-Xaa. Inhibited by the effector protein NleF that is produced by pathogenic E.coli; this inhibits apoptosis.
Anti-Caspase 9 -http://www.stjohnslabs.com/caspase-9-antibody-p-98614
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
CD5 is a cluster of differentiation expressed on the surface of T cells (various species) and in a subset of murine B cells known as B-1a. The expression of this receptor in human B cells has been a controversial topic and up to date there is no consensus regarding the role of this receptor as a marker of human B cells. B-1 cells have limited diversity of their B-cell receptor due to their lack of the enzyme terminal deoxynucleotidyl transferase (TdT) and are potentially self-reactive. CD5 serves to mitigate activating signals from the BCR so that the B-1 cells can only be activated by very strong stimuli (such as bacterial proteins) and not by normal tissue proteins. CD5 was used as a T-cell marker until monoclonal antibodies against CD3 were developed.
Anti-CD5 -http://www.stjohnslabs.com/cd5-antibody-p-98608
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Transcriptional regulator which can act both as a coactivator and a corepressor and is the critical downstream regulatory target in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis . The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ . Plays a key role in tissue tension and 3D tissue shape by regulating cortical actomyosin network formation.
Anti-YAP -http://www.stjohnslabs.com/yap-antibody-p-94815
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Growth factor that plays an essential role in the regulation of embryonic development, cell proliferation, cell migration, survival and chemotaxis. Potent mitogen for cells of mesenchymal origin . Required for normal proliferation and recruitment of pericytes and vascular smooth muscle cells in the central nervous system, skin, lung, heart and placenta. Required for normal blood vessel development, and for normal development of kidney glomeruli. Plays an important role in wound healing. Signaling is modulated by the formation of heterodimers with PDGFA.
Anti-PDGF-B -http://www.stjohnslabs.com/pdgf-b-antibody
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Microbial assays or microbiological assays could be a sort of bioassays designed to analyse the compounds or substances that have impact on micro-organisms. They help to estimate concentration and efficiency of antibiotics. Also facilitate in determination of the simplest anti-biotic appropriate for patient recovery.
Protein tyrosine kinase that is part of several cell surface receptor complexes, but that apparently needs a coreceptor for ligand binding. Essential component of a neuregulin-receptor complex, although neuregulins do not interact with it alone. GP30 is a potential ligand for this receptor. Regulates outgrowth and stabilization of peripheral microtubules (MTs). Upon ERBB2 activation, the MEMO1-RHOA-DIAPH1 signaling pathway elicits the phosphorylation and thus the inhibition of GSK3B at cell membrane. This prevents the phosphorylation of APC and CLASP2, allowing its association with the cell membrane. In turn, membrane-bound APC allows the localization of MACF1 to the cell membrane, which is required for microtubule capture and stabilization.
Anti-HER2 -http://www.stjohnslabs.com/her2-antibody-p-98582
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Receptor-regulated SMAD (R-SMAD) that is an intracellular signal transducer and transcriptional modulator activated by TGF-beta (transforming growth factor) and activin type 1 receptor kinases. Binds the TRE element in the promoter region of many genes that are regulated by TGF-beta and, on formation of the SMAD2/SMAD4 complex, activates transcription. May act as a tumor suppressor in colorectal carcinoma. Positively regulates PDPK1 kinase activity by stimulating its dissociation from the 14-3-3 protein YWHAQ which acts as a negative regulator.
Anti-Smad2 -http://www.stjohnslabs.com/smad2-antibody-p-94356
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Keratin 16 is a protein that in humans is encoded by the KRT16 gene.
Keratin 16 is a type I cytokeratin. It is paired with keratin 6 in a number of epithelial tissues, including nail bed, esophagus, tongue, and hair follicles. Mutations in the gene encoding this protein are associated with the genetic skin disorders pachyonychia congenita, non-epidermolytic palmoplantar keratoderma and unilateral palmoplantar verrucous nevus.
Anti-CK16 -http://www.stjohnslabs.com/ck16-antibody-p-98593
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Key regulator of entry into cell division that acts as a tumor suppressor. Promotes G0-G1 transition when phosphorylated by CDK3/cyclin-C. Acts as a transcription repressor of E2F1 target genes. The underphosphorylated, active form of RB1 interacts with E2F1 and represses its transcription activity, leading to cell cycle arrest. Directly involved in heterochromatin formation by maintaining overall chromatin structure and, in particular, that of constitutive heterochromatin by stabilizing histone methylation. Recruits and targets histone methyltransferases SUV39H1, KMT5B and KMT5C, leading to epigenetic transcriptional repression.
Anti-Rb -http://www.stjohnslabs.com/rb-antibody-p-94135
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Probably plays a role in facilitating the assembly of multimeric protein complexes inside the endoplasmic reticulum. Involved in the correct folding of proteins and degradation of misfolded proteins via its interaction with DNAJC10, probably to facilitate the release of DNAJC10 from its substrate
Anti-HSP A5 -http://www.stjohnslabs.com/hsp-a5-antibody
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Drug efflux transporter present in a number of stem cells that acts as a regulator of cellular differentiation. Able to mediate efflux from cells of the rhodamine dye and of the therapeutic drug doxorubicin. Specifically present in limbal stem cells, where it plays a key role in corneal development and repair.
Anti-ABCB5 -http://www.stjohnslabs.com/abcb5-antibody-p-98611
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Protein tyrosine kinase that is part of several cell surface receptor complexes, but that apparently needs a coreceptor for ligand binding. Essential component of a neuregulin-receptor complex, although neuregulins do not interact with it alone. GP30 is a potential ligand for this receptor. Regulates outgrowth and stabilization of peripheral microtubules (MTs). Upon ERBB2 activation, the MEMO1-RHOA-DIAPH1 signaling pathway elicits the phosphorylation and thus the inhibition of GSK3B at cell membrane. This prevents the phosphorylation of APC and CLASP2, allowing its association with the cell membrane. In turn, membrane-bound APC allows the localization of MACF1 to the cell membrane, which is required for microtubule capture and stabilization.
Anti-HER2 -http://www.stjohnslabs.com/her2-antibody-p-98582
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Tyrosine kinase of the non-receptor type, involved in the IFN-alpha/beta/gamma signal pathway . Kinase partner for the interleukin (IL)-2 receptor. ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.
Anti-JAK1 -http://www.stjohnslabs.com/jak1-antibody-p-92863
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation.
Anti-p70 S6 kinase α -http://www.stjohnslabs.com/p70-s6-kinase-a-antibody-p-93776
Join our Antibody Validation Project - http://www.stjohnslabs.com/services/antibody-validation
Biol 390 – Lab 8 Restriction Digest and Gel Electrophoresis .docxmoirarandell
Biol 390 – Lab 8 Restriction Digest and Gel Electrophoresis
2
Objective
· Digest DNA of pGLO plasmid using restriction endonuclease enzymes.
· Run an agarose gel to separate the DNA fragments.
Background
Restriction enzymes cut DNA at specific sites generating a number of different sized fragments. The size of the fragments will depend on the number of sites the plasmid has and the specific enzyme used. The number of fragments can be predicted by viewing the map of the plasmid
Gel electrophoresis is a means of separating DNA in an electrical field. DNA is negatively charged and so will move to the anode (+). Larger fragments will move slower through the agarose matrix than the smaller molecules. Agarose is a polysaccharide polymer derived from seaweed: it is a purified from agar by removing the agaropectin component. Fragments are visualized using ethidium bromide, which will glow orange when exposed to UV light.
Materials
Restriction digest
· Restriction enzymes: Nhe1 and EcoR1 (New England Biolabs) – (KEEP ON ICE)
· Plasmid prepared in lab 7
· NanoDrop Lite spectrophotometer
· Microfuge tubes – Sterile
· 37 C degree bath – block heater
· Sterile 10ul and 200ul tips
· Bleach bottles for cleaning bench
· 10X NE Cut Smart Buffer – comes with enzyme
· Nitrile gloves
· Sterile DI water
· Shaved ice
· Ice block for enzymes
Gel Electrophoresis
· Agarose
· Sterile miliQ Water
· 15 well comb
· 50x TAE buffer
· DNA ladder – diluted in sample buffer (1 KB)
· Gel loading dye
· Gel electrophoresis chamber
· Power supply
· Ethidium bromide
· Gel Sys – visualization system
_______________________________________________
Procedure
Restriction Digest of plasmid DNA
· Safety: Wear nitrile gloves – prevent DNAase from your hands affecting the reaction and protect yourself from ethidium bromide
· Clean the bench with bleach - prevents exogenous enzymes interfering you’re your digests.
· Use the NanoDrop to determine the amount of DNA in your plasmid prep. Use this information to calculate how much sample you need to pipette into the reaction mix.
· Label an Eppendorf tube ‘+’ and another ‘-‘
· Make up a reaction mix in both tubes as follows for one of your plasmid samples
· add 1ug of DNA from your plasmid prep
· 5ul of 10X NE Cut Smart Buffer
· Sterile DI water to make the reaction mix to 50ul
For the + tube
· DNA
x ul
· 10X NE Cut Smart Buffer
5ul
· Nhe1 (add last to + tube)
1ul
· EcoR1 (add last to + tube)
1ul
· Sterile DI water
To make final volume to 50ul
· Add the restriction enzymes last to the + tube ONLY
· Repeat with the other two plasmid samples
For the – tube
· DNA
x ul
· 10X NE Buffer
5ul
· Nhe1
None
· EcoR1
None
· Sterile DI water
To make final volume to 50ul
· Do not add any enzyme to the ‘-‘ tube
· Repeat with the other two plasmid samples
· Mix the tubes by flicking – DO NOT VORTEX
· Give a 5 second spin in the centrifuge to bring the contents to the bottom
· Incu.
Microbial Assay of Antibiotics
STANDARD PREPARATION AND UNITS OF ACTIVITY
Preparation of media
Buffer solutions
Standard solution
Sample solution
Test organisms
Preparation of inoculum Method -1
Method 2
Method 3
Method 4
Determination of Inoculum
Apparatus
Assay design
Assay method
cylinder plate method
One level assay with standard curve
Estimation of potency
Turbidimetric method
The main purpose of these slides is to convey information to the Professors, Lecturers, and Students. These slides contain authentic information about this topic which is mentioned in that.
Feiyuebio as manufacurer Supply ELISA kits,Antibody with High Quality and Safe Ship.
For sale:+8618071549908
SEMA3G(Semaphorin-3G) Basic information
Semaphorins are a class of secreted and membrane proteins that were originally identified as axonal growth cone guidance molecules. They primarily act as short-range inhibitory signals and signal through multimeric receptor complexes. Semaphorins are usually cues to deflect axons from inappropriate regions, especially important in the neural system development. The major class of proteins that act as their receptors are called plexins, with neuropilins as their co-receptors in many cases. The main receptors for semaphorins are plexins, which have established roles in regulating Rho-family GTPases. Recent work shows that plexins can also influence R-Ras, which, in turn, can regulate integrins. Such regulation is probably a common feature of semaphorin signalling and contributes substantially to our understanding of semaphorin biology.
Human SEMA3G(Semaphorin-3G) ELISA Kit test method
Feiyue’s Human SEMA3G (Semaphorin-3G) Elisa kit is an ELISA reagent for detection of Neutrophil elastase in serum, plasma, tissue homogenates and other biological fluids.
This kit uses sandwich ELISA to detect the concentration of Semaphorin-3G . SEMA3G (Semaphorin-3G) -specific monoclonal antibody has been pre-coated in the wells of the supplied microplate. Standards samples and controls are added to interact with the immobilized antibody. A sandwich complex is formed by additional anti- SEMA3G (Semaphorin-3G) antibody with HRP-Streptavidin. TMB solution is added to react with the sandwich for ming optical signal measured by microplate reader. The concentration of SEMA3G (Semaphorin-3G) in the sample can be calculated by comparing the absorbance of the sample with the standard curve.
Conjugation is the method of adding an antigen to a larger molecule that ensures that the antigen stimulates the immune response that generates antibodies.
This guide is key to successful IHC experiments. Since no universal tissue preparation method will be ideal for all sample and tissue types, all protocols given here are intended as a starting point from which the experimenter must optimize as needed.
Immunohistochemistry (IHC) is a method that combines biochemical, histological and immunological techniques into a simple but powerful assay for protein detection. IHC provides valuable information as it visualizes the distribution and localization of specific cellular components within cells and in proper tissue context.
Fa cs sample preparation & protocolJames Waita
Fluorescent activated cell sorting (FACS) is a specialized type of flow cytometry used for sorting and analyzing a heterogeneous mixture of cells into different subpopulations based on the specific light scattering and fluorescent characteristics (from the specific labels) of each cell.
Fluorescent activated cell sorting (FACS) is a specialized type of flow cytometry used for sorting and analyzing a heterogeneous mixture of cells into different sub- populations based on the specific light scattering and fluorescent characteristics (from the specific labels) of each cell.
Western blotting WB (immunoblotting) is a widely practiced analytical technique to detect target proteins within samples using antigen-specific antibodies.
ELISA troubleshooting guide serves as a checklist for the possible causes and solutions with respect to some of the most commonly encountered problems from the ELISA assays.
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...University of Maribor
Slides from:
11th International Conference on Electrical, Electronics and Computer Engineering (IcETRAN), Niš, 3-6 June 2024
Track: Artificial Intelligence
https://www.etran.rs/2024/en/home-english/
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Ana Luísa Pinho
Functional Magnetic Resonance Imaging (fMRI) provides means to characterize brain activations in response to behavior. However, cognitive neuroscience has been limited to group-level effects referring to the performance of specific tasks. To obtain the functional profile of elementary cognitive mechanisms, the combination of brain responses to many tasks is required. Yet, to date, both structural atlases and parcellation-based activations do not fully account for cognitive function and still present several limitations. Further, they do not adapt overall to individual characteristics. In this talk, I will give an account of deep-behavioral phenotyping strategies, namely data-driven methods in large task-fMRI datasets, to optimize functional brain-data collection and improve inference of effects-of-interest related to mental processes. Key to this approach is the employment of fast multi-functional paradigms rich on features that can be well parametrized and, consequently, facilitate the creation of psycho-physiological constructs to be modelled with imaging data. Particular emphasis will be given to music stimuli when studying high-order cognitive mechanisms, due to their ecological nature and quality to enable complex behavior compounded by discrete entities. I will also discuss how deep-behavioral phenotyping and individualized models applied to neuroimaging data can better account for the subject-specific organization of domain-general cognitive systems in the human brain. Finally, the accumulation of functional brain signatures brings the possibility to clarify relationships among tasks and create a univocal link between brain systems and mental functions through: (1) the development of ontologies proposing an organization of cognitive processes; and (2) brain-network taxonomies describing functional specialization. To this end, tools to improve commensurability in cognitive science are necessary, such as public repositories, ontology-based platforms and automated meta-analysis tools. I will thus discuss some brain-atlasing resources currently under development, and their applicability in cognitive as well as clinical neuroscience.
Richard's aventures in two entangled wonderlandsRichard Gill
Since the loophole-free Bell experiments of 2020 and the Nobel prizes in physics of 2022, critics of Bell's work have retreated to the fortress of super-determinism. Now, super-determinism is a derogatory word - it just means "determinism". Palmer, Hance and Hossenfelder argue that quantum mechanics and determinism are not incompatible, using a sophisticated mathematical construction based on a subtle thinning of allowed states and measurements in quantum mechanics, such that what is left appears to make Bell's argument fail, without altering the empirical predictions of quantum mechanics. I think however that it is a smoke screen, and the slogan "lost in math" comes to my mind. I will discuss some other recent disproofs of Bell's theorem using the language of causality based on causal graphs. Causal thinking is also central to law and justice. I will mention surprising connections to my work on serial killer nurse cases, in particular the Dutch case of Lucia de Berk and the current UK case of Lucy Letby.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.Sérgio Sacani
The return of a sample of near-surface atmosphere from Mars would facilitate answers to several first-order science questions surrounding the formation and evolution of the planet. One of the important aspects of terrestrial planet formation in general is the role that primary atmospheres played in influencing the chemistry and structure of the planets and their antecedents. Studies of the martian atmosphere can be used to investigate the role of a primary atmosphere in its history. Atmosphere samples would also inform our understanding of the near-surface chemistry of the planet, and ultimately the prospects for life. High-precision isotopic analyses of constituent gases are needed to address these questions, requiring that the analyses are made on returned samples rather than in situ.
Slide 1: Title Slide
Extrachromosomal Inheritance
Slide 2: Introduction to Extrachromosomal Inheritance
Definition: Extrachromosomal inheritance refers to the transmission of genetic material that is not found within the nucleus.
Key Components: Involves genes located in mitochondria, chloroplasts, and plasmids.
Slide 3: Mitochondrial Inheritance
Mitochondria: Organelles responsible for energy production.
Mitochondrial DNA (mtDNA): Circular DNA molecule found in mitochondria.
Inheritance Pattern: Maternally inherited, meaning it is passed from mothers to all their offspring.
Diseases: Examples include Leber’s hereditary optic neuropathy (LHON) and mitochondrial myopathy.
Slide 4: Chloroplast Inheritance
Chloroplasts: Organelles responsible for photosynthesis in plants.
Chloroplast DNA (cpDNA): Circular DNA molecule found in chloroplasts.
Inheritance Pattern: Often maternally inherited in most plants, but can vary in some species.
Examples: Variegation in plants, where leaf color patterns are determined by chloroplast DNA.
Slide 5: Plasmid Inheritance
Plasmids: Small, circular DNA molecules found in bacteria and some eukaryotes.
Features: Can carry antibiotic resistance genes and can be transferred between cells through processes like conjugation.
Significance: Important in biotechnology for gene cloning and genetic engineering.
Slide 6: Mechanisms of Extrachromosomal Inheritance
Non-Mendelian Patterns: Do not follow Mendel’s laws of inheritance.
Cytoplasmic Segregation: During cell division, organelles like mitochondria and chloroplasts are randomly distributed to daughter cells.
Heteroplasmy: Presence of more than one type of organellar genome within a cell, leading to variation in expression.
Slide 7: Examples of Extrachromosomal Inheritance
Four O’clock Plant (Mirabilis jalapa): Shows variegated leaves due to different cpDNA in leaf cells.
Petite Mutants in Yeast: Result from mutations in mitochondrial DNA affecting respiration.
Slide 8: Importance of Extrachromosomal Inheritance
Evolution: Provides insight into the evolution of eukaryotic cells.
Medicine: Understanding mitochondrial inheritance helps in diagnosing and treating mitochondrial diseases.
Agriculture: Chloroplast inheritance can be used in plant breeding and genetic modification.
Slide 9: Recent Research and Advances
Gene Editing: Techniques like CRISPR-Cas9 are being used to edit mitochondrial and chloroplast DNA.
Therapies: Development of mitochondrial replacement therapy (MRT) for preventing mitochondrial diseases.
Slide 10: Conclusion
Summary: Extrachromosomal inheritance involves the transmission of genetic material outside the nucleus and plays a crucial role in genetics, medicine, and biotechnology.
Future Directions: Continued research and technological advancements hold promise for new treatments and applications.
Slide 11: Questions and Discussion
Invite Audience: Open the floor for any questions or further discussion on the topic.
Nutraceutical market, scope and growth: Herbal drug technologyLokesh Patil
As consumer awareness of health and wellness rises, the nutraceutical market—which includes goods like functional meals, drinks, and dietary supplements that provide health advantages beyond basic nutrition—is growing significantly. As healthcare expenses rise, the population ages, and people want natural and preventative health solutions more and more, this industry is increasing quickly. Further driving market expansion are product formulation innovations and the use of cutting-edge technology for customized nutrition. With its worldwide reach, the nutraceutical industry is expected to keep growing and provide significant chances for research and investment in a number of categories, including vitamins, minerals, probiotics, and herbal supplements.
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Sérgio Sacani
We characterize the earliest galaxy population in the JADES Origins Field (JOF), the deepest
imaging field observed with JWST. We make use of the ancillary Hubble optical images (5 filters
spanning 0.4−0.9µm) and novel JWST images with 14 filters spanning 0.8−5µm, including 7 mediumband filters, and reaching total exposure times of up to 46 hours per filter. We combine all our data
at > 2.3µm to construct an ultradeep image, reaching as deep as ≈ 31.4 AB mag in the stack and
30.3-31.0 AB mag (5σ, r = 0.1” circular aperture) in individual filters. We measure photometric
redshifts and use robust selection criteria to identify a sample of eight galaxy candidates at redshifts
z = 11.5 − 15. These objects show compact half-light radii of R1/2 ∼ 50 − 200pc, stellar masses of
M⋆ ∼ 107−108M⊙, and star-formation rates of SFR ∼ 0.1−1 M⊙ yr−1
. Our search finds no candidates
at 15 < z < 20, placing upper limits at these redshifts. We develop a forward modeling approach to
infer the properties of the evolving luminosity function without binning in redshift or luminosity that
marginalizes over the photometric redshift uncertainty of our candidate galaxies and incorporates the
impact of non-detections. We find a z = 12 luminosity function in good agreement with prior results,
and that the luminosity function normalization and UV luminosity density decline by a factor of ∼ 2.5
from z = 12 to z = 14. We discuss the possible implications of our results in the context of theoretical
models for evolution of the dark matter halo mass function.
What is greenhouse gasses and how many gasses are there to affect the Earth.moosaasad1975
What are greenhouse gasses how they affect the earth and its environment what is the future of the environment and earth how the weather and the climate effects.
2. Types of ELISA
Basically there are 4 different types of ELISA namely;
1. Direct ELISA
2. Indirect ELISA
3. Sandwich ELISA
4. Competitive ELISA
3. Direct ELISA
For direct detection, an antigen coated to a multi-well plate is detected by an antibody that has been directly conjugated to an
enzyme. This detection method is a good option if there is no commercially available ELISA kits for your target protein.
1. Advantages
● Quick because only one antibody and fewer steps are used.
● Cross-reactivity of secondary antibody is eliminated.
1. Disadvantages
● Cell Smear: Adhere non-adherent cells on coverslip with chemical bond
● Immunoreactivity of the primary antibody might be adversely affected by labeling with enzymes or tags.
● Labeling primary antibodies for each specific ELISA system is time-consuming and expensive.
● No flexibility in choice of primary antibody label from one experiment to another.
● Minimal signal amplification.
4. Direct Elisa Procedure
This is a general protocol in which antigen coating and blocking may not be required if the wells from the
manufacturer have been pre-adsorbed with the antigen.
1. Antigen Coating
● Dilute purified antigens to a final concentration of 1-10 μg/ml in bicarbonate/carbonate antigen-
coating
● Buffer (100 mM NaHCO3 in deionized water; pH adjusted to 9.6).
● Pipette 100 μL of diluted antigen to each well of a microtiter plate.
● Cover the plate with adhesive plastic and incubate at 4°C overnight (or 37C for 30 min).
● Remove the coating solution and wash the plate 3X with 200 μL PBS (Phosphate Buffered Saline)
buffer (10 mM Na2HPO4 and 1.8 mM NaH2PO4 in deionized water with 0.2% Tween 20; pH
Adjusted to 7.4) with for 5 minutes each time. The coating/washing solutions can be removed by
flicking the plate over a sink. The remaining drops can be removed by patting the plate on a paper
towel or by aspiration. Do not allow the wells to dry out at any time.
5. Direct Elisa Procedure
2. Blocking
● Pipette 200 μL blocking buffer (5% w/v non-fat dry milk in PBS buffer) per well to block residual
protein-binding sites. Alternatively, BSA or BlockACE can be used to replace non-fat dry milk.
● Cover the plate with adhesive plastic and incubate for 1-2 hour(s) at 37°C (or at 4°C overnight).
● Remove the blocking solution and wash the plate 2X with 200 μL PBS for 5 min each time. Flick the plate
and pat the plate as described in the coating step.
3. Reagent Preparation
● Prepare for the diluted standard solutions.
6. Direct Elisa Procedure
4. Primary Antibody Incubation
● Serially dilute the conjugated primary antibody with blocking buffer immediately before use. The
optimal dilution should be determined by a titration assay according to the antibody
manufacturer.
● Pipette 100 μL of diluted secondary antibody solution to each well.
● Cover the plate with adhesive plastic and incubate for 2 hours at room temperature.
● Remove the content in the wells and wash them 3X with 200 μL PBS buffer for 5 min each time.
Flick the plate and pat the plate as described in the coating step.
5. Substrate Preparation
Prepare the substrate solution immediately before use or bring the pre-made substrate to room
temperature. The two widely used enzymes for signal detection are horse radish peroxidase (HRP) and
alkaline phosphatase (AP), and their corresponding substrates, stopping solutions, detection absorbance
wavelengths and color developed are as follows:
7. Direct Elisa Procedure
● The TMB substrate must be kept at 37°C for 30 min before use.
● Hydrogen peroxide can also act as a substrate for HRP.
● Sodium azide is an inhibitor of HRP. Do not include the azide in buffers or wash solutions if HRP-
labeled conjugate is used for detection.
8. Direct Elisa Procedure
6. Signal Detection
● Pipette 90 μL of substrate solution to the wells with the control and standard solutions.
● Incubate the plate at 37°C in the dark. If TMB is used, shades of blue will be observed in the wells
with the most concentrated solutions. Other wells may show no obvious color.
● Color should be developed in positive wells after 15 min. After sufficient color development,
pipette 100 μL of stopping solution to the wells (if necessary).
● Read the absorbance (OD: Optical Density) of each well with a plate reader.
7. Data Analysis
● Prepare a standard curve using the data produced from the diluted standard solutions. Use
absorbance on the Y-axis (linear) and concentration on the X-axis (log scale).
● Interpret the sample concentration from the standard curve.
9. Indirect ELISA
For indirect detection, the antigen coated to a multi-well plate is detected in two stages or layers. First an unlabeled primary
antibody, which is specific for the antigen, is applied. Next, an enzyme-labeled secondary antibody is bound to the first
antibody. The secondary antibody is usually an anti-species antibody and is often polyclonal. The indirect assay, the most
popular format for ELISA, has the advantages and disadvantages:
1. Advantages
● A wide variety of labeled secondary antibodies are available commercially.
● Versatile because many primary antibodies can be made in one species and the same labeled secondary antibody can
be used for detection.
● Maximum immunoreactivity of the primary antibody is retained because it is not labeled.
● Sensitivity is increased because each primary antibody contains several epitopes that can be bound by the labeled
secondary antibody, allowing for signal amplification.
1. Disadvantages
● Cell Smear: Adhere non-adherent cells on coverslip with chemical bond
● Cross-reactivity might occur with the secondary antibody, resulting in nonspecific signal.
● An extra incubation step is required in the procedure.
10. Indirect ELISA Procedure
This is a general protocol in which antigen coating and blocking may not be required if the wells from the
manufacturer have been pre-adsorbed with the antigen.
1. Antigen Coating
● Dilute purified antigens to a final concentration of 1-10 μg/mL in bicarbonate/carbonate antigen-
coating
● Buffer (100 mM NaHCO3 in deionized water; pH adjusted to 9.6).
● Pipette 100 μL of diluted antigen to each well of a microtiter plate.
● Cover the plate with adhesive plastic and incubate at 4°C overnight (or 37°C for 30 min).
● Remove the coating solution and wash the plate 3X with 200 μL PBS (Phosphate Buffered Saline)
buffer (10 mM Na2HPO4 and 1.8 mM NaH2PO4 in deionized water with 0.2% Tween 20; pH
Adjusted to 7.4) with for 5 minutes each time. The coating/washing solutions can be removed by
flicking the plate over a sink. The remaining drops can be removed by patting the plate on a paper
towel or by aspiration. Do not allow the wells to dry out at any time.
11. Indirect ELISA Procedure
2. Blocking
● Pipette 200 μL blocking buffer (5% w/v non-fat dry milk in PBS buffer) per well to block residual
protein-binding sites. Alternatively, BSA or BlockACE can be used to replace non-fat dry milk.
● Cover the plate with adhesive plastic and incubate for 1-2 hour(s) at 37°C (or at 4°C overnight).
● Remove the blocking solution and wash the plate 2X with 200 μL PBS for 5 minutes each time.
Flick the plate and pat the plate as described in the coating step.
3. Reagent Preparation
● Prepare for the diluted standard solutions
12. Indirect ELISA Procedure
4. Primary Antibody Incubation
● Serially dilute the primary antibody of choice with blocking buffer. The optimal dilution should be
determined by a titration assay according to the antibody manufacturer.
● Pipette 100 μL of each diluted antibody per well. Repeat in duplicate or triplicate for accuracy. The
negative control should be species- and isotype-matched as well as non-specific immunoglobulin
diluted in PBS buffer.
● Cover the plate with adhesive plastic and incubate for 1 hour at 37°C (or 2 hours at room
temperature). These incubation times should be sufficient to receive a strong signal. However, if a
weak signal is observed, perform incubation overnight at 4°C for a stronger signal.
● Remove the diluted antibody solution and wash the wells 3X with 200 μL PBS for 5 min each time.
Flick the plate and pat the plate as described in the coating step.
● Serially dilute the primary antibody of choice with blocking buffer. The optimal dilution should be
determined by a titration assay according to the antibody manufacturer.
13. Indirect ELISA Procedure
● Pipette 100 μL of each diluted antibody per well. Repeat in duplicate or triplicate for accuracy. The
negative control should be species- and isotype-matched as well as non-specific immunoglobulin
diluted in PBS buffer.
● Cover the plate with adhesive plastic and incubate for 1 hour at 37°C (or 2 hours at room
temperature). These incubation times should be sufficient to receive a strong signal. However, if a
weak signal is observed, perform incubation overnight at 4°C for a stronger signal.
● Remove the diluted antibody solution and wash the wells 3X with 200 μL PBS for 5 min each time.
Flick the plate and pat the plate as described in the coating step.
5. Secondary Antibody Incubation
● Serially dilute the conjugated secondary antibody with blocking buffer immediately before use.
The optimal dilution should be determined by a titration assay according to the antibody
manufacturer.
● Pipette 100 μL of diluted secondary antibody solution to each well.
14. Indirect ELISA Procedure
● Cover the plate with adhesive plastic and incubate for 2 hours at room temperature.
● Remove the content in the wells and wash them 3X with 200 μL PBS buffer for 5 min each time.
Flick the plate and pat the plate as described in the coating step.
6. Substrate Preparation
Prepare the substrate solution immediately before use or bring the pre-made substrate to room
temperature. The two widely used enzymes for signal detection are horse radish peroxidase (HRP) and
alkaline phosphatase (AP), and their corresponding substrates, stopping solutions, detection absorbance
wavelengths and color developed are as follows:
15. Indirect ELISA Procedure
Note:
● The TMB substrate must be kept at 37°C for 30 min before use.
● Hydrogen peroxide can also act as a substrate for HRP.
● Sodium azide is an inhibitor of HRP. Do not include the azide in buffers or wash solutions if HRP-
labeled conjugate is used for detection.
7. Signal Detection
● Pipette 90 μL of substrate solution to the wells with the control and standard solutions.
● Incubate the plate at 37°C in the dark. If TMB is used, shades of blue will be observed in the wells
with the most concentrated solutions. Other wells may show no obvious color.
● Color should be developed in positive wells after 15 min. After sufficient color development,
pipette 100 μL of stop solution to the wells (if necessary).
● Read the absorbance (OD: Optical Density) of each well with a plate reader.
16. Indirect ELISA Procedure
8. Data Analysis
● Prepare a standard curve using the data produced from the diluted standard solutions. Use
absorbance on the Y-axis (linear) and concentration on the X-axis (log scale).
● Interpret the sample concentration from the standard curve.
17. Sandwich ELISA
Sandwich ELISAs typically require the use of matched antibody pairs, where each antibody is specific for a different, non-
overlapping part (epitope) of the antigen molecule. A first antibody (known as capture antibody) is coated to the wells. The
sample solution is then added to the well. A second antibody (known as detection antibody) follows this step in order to
measure the concentration of the sample. This type of ELISA has the following advantages:
● High specificity: the antigen/analyte is specifically captured and detected
● Suitable for complex (or crude/impure) samples: the antigen does not require purification prior to measurement
● Flexibility and sensitivity: both direct or indirect detection methods can be used
18. Sandwich ELISA Procedure
All of the ELISA kits from Boster use the sandwich format and avidin-biotin chemistry. Our ELISA assays
require the dilutions of standard solutions, biotinylated antibody (detection antibody) and avidin-biotin-
peroxidase.
1. Capture Antibody Coating
● (These steps are not required if the pre-adsorbed Picokine ELISA kits from Boster are used)
● Dilute the capture antibody to a final concentration of 1-10 μg/mL in bicarbonate/carbonate
antigen-coating buffer (100 mM NaHCO3 in deionized water; pH adjusted to 9.6).
● Pipette 100 μL of diluted antibody to each well of a microtiter plate.
● Cover the plate with adhesive plastic and incubate at 4°C overnight (or 37°C for 30 min).
● Remove the coating solution and wash the plate 3X with 200 μL PBS (Phosphate Buffered Saline)
buffer (10 mM Na2HPO4 and 1.8 mM NaH2PO4 in deionized water with 0.2% Tween 20; pH
Adjusted to 7.4) with for 5 minutes each time. The coating/washing solutions can be removed by
flicking the plate over a sink. The remaining drops can be removed by patting the plate on a paper
towel or by aspiration. Do not allow the wells to dry out at any time.
19. Sandwich ELISA Procedure
2. Blocking
● (These steps are not required if the pre-adsorbed Picokine ELISA kits from Boster are used)
● Pipette 200 μL blocking buffer (5% w/v non-fat dry milk in PBS buffer) per well to block residual
protein-binding sites. Alternatively, BSA or BlockACE can be used to replace non-fat dry milk.
● Cover the plate with adhesive plastic and incubate for 1-2 hour(s) at 37°C (or at 4°C overnight).
● Remove the blocking solution and wash the plate 2X with 200 μL PBS for 5 minutes each time.
Flick the plate and pat the plate as described in the coating step.
3. Reagent Preparation
Prepare for the diluted standard solutions, biotinylated antibody and ABC solutions as
20. Sandwich ELISA Procedure
4. Sample (Antigen) Incubation
● Serially dilute the sample with blocking buffer immediately before use. The optimal dilution should
be determined by a titration assay according to the antibody manufacturer.
● Pipette 100 μL of each of the diluted sample solutions and control to each empty well. Repeat in
duplicate or triplicate for accuracy. The negative control should be species- and isotype-matched
as well as non- specific immunoglobulin diluted in PBS buffer.
● Cover the plate with adhesive plastic and incubate for 2 hours at room temperature.
● Remove the content in the wells and wash them 3X with 200 μL PBS buffer for 5 minutes each
time. Flick the plate and pat the plate as described in the coating step.
21. Sandwich ELISA Procedure
5. Biotinylated Antibody Incubation
● Pipette 100 μL of diluted antibody to the wells with control, standard solutions and diluted
samples.
● Cover the plate with adhesive plastic and incubate for 1 hour at 37°C (or 2 hours at room
temperature). These incubation times should be sufficient to receive a strong signal. However, if a
weak signal is observed, perform incubation overnight at 4°C for a stronger signal.
● Remove the content in the wells and wash them 3X with 200 μL PBS for 5 min each time. Flick the
plate and pat the plate as described in the coating step.
6. ABC Incubation
● Pipette 100 μL of diluted ABC solution to the wells with control, standard solutions and diluted
samples.
● Cover the plate with adhesive plastic and incubate for 0.5 hour at 37°C.
● Remove the content in the wells and wash them 3X with 200 μL PBS buffer for 5 min each time.
22. Sandwich ELISA Procedure
7. Substrate Preparation
Prepare the substrate solution immediately before use or bring the pre-made substrate to room
temperature. The two widely used enzymes for signal detection are horse radish peroxidase (HRP) and
alkaline phosphatase (AP), and their corresponding substrates, stopping solutions, detection absorbance
wavelengths and color developed are as follows:
● The TMB substrate must be kept at 37°C for 30 min before use.
● Hydrogen peroxide can also act as a substrate for HRP.
● Sodium azide is an inhibitor of HRP. Do not include the azide in buffers or wash solutions if HRP-
labeled conjugate is used for detection.
23. Sandwich ELISA Procedure
8. Signal Detection
● Pipette 90 μL of substrate solution to the wells with the control, standard solutions and diluted
samples.
● Incubate the plate at 37°C in the dark. If TMB is used, shades of blue will be observed in the wells with
the most concentrated solutions. Other wells may show no obvious color.
● Color should be developed in positive wells after 15 min. After sufficient color development, pipette
100 μL of stop solution to the appropriate wells (if necessary).
● Read the absorbance (OD: Optical Density) of each well with a plate reader.
9. Data Analysis
● Prepare a standard curve using the data produced from the diluted standard solutions. Use
absorbance on the Y-axis (linear) and concentration on the X-axis (log scale).
● Interpret the sample concentration from the standard curve.
24. Competitive ELISA Procedure
This ELISA kit is of competitive format. Competitive ELISA, also known as inhibition ELISA, is a surface/plate based assay,
where the plate is coated with capture antibodies reactive to the molecule of interest. The sample (containing native molecule
of interest) and enzyme conjugated recombinant protein (the competing molecule) are added to the coated wells. Since the
amount of enzyme conjugated molecule in each well is constant, the level of native molecule in the sample will determine the
binding ratio of enzyme conjugated molecule vs. native molecule. After an incubation period, any unbound antibody is washed
off. Enzyme substrate (for example, TMB for HRP) is added to each well and will be transformed into a blue precipitate, the
amount of which is linearly proportional to the amount of enzyme in the well. The precipitate is then turned into yellow by
adding the acid stop solution and the concentration of yellow precipitate is read at 450nm for light absorbance (O.D. value).
The O.D. is then used to calculate the amount of molecule of interest in each well, by comparing each sample well against the
standard curve. The standard curve is generated using the same principle but instead of adding samples, a series of
recombinant molecules with known concentrations are added to 6-8 wells.
25. Competitive ELISA Procedure
This is a general protocol in which antigen coating and blocking may not be required if the wells from the
manufacturer have been pre-adsorbed with the antigen.
1. Antigen Coating
● Dilute purified antigens to a final concentration of 20 μg/ml in bicarbonate/carbonate antigen-
coating
● Buffer (100 mM NaHCO3 in deionized water; pH adjusted to 9.6).
● Pipette 100 μL of diluted antigen to each well of a microtiter plate.
● Cover the plate with adhesive plastic and incubate at 4°C overnight (or 37C for 30 min).
● Remove the coating solution and wash the plate 3X with 200 μL PBS (Phosphate Buffered Saline)
buffer (10 mM Na2HPO4 and 1.8 mM NaH2PO4 in deionized water with 0.2% Tween 20; pH
Adjusted to 7.4) with for 5 minutes each time. The coating/washing solutions can be removed by
flicking the plate over a sink. The remaining drops can be removed by patting the plate on a paper
towel or by aspiration. Do not allow the wells to dry out at any time.
26. Competitive ELISA Procedure
2. Blocking
Pipette 200 μL blocking buffer (5% w/v non-fat dry milk in PBS buffer) per well to block residual protein-
binding sites. Alternatively, BSA or BlockACE can be used to replace non-fat dry milk.
Cover the plate with adhesive plastic and incubate for 1-2 hour(s) at 37°C (or at 4°C overnight).
Remove the blocking solution and wash the plate 2X with 200 μL PBS for 5 min each time. Flick the plate
and pat the plate as described in the coating step.
3. Reagent Preparation
a. Prepare for the diluted standard solutions
27. Competitive ELISA Procedure
4. Sample (Antigen) Incubation
a. Serially dilute the sample with blocking buffer immediately before use. The optimal dilution should be
determined by a titration assay according to the antibody manufacturer.
b. Pipette 100 μL of diluted sample to each well.
c. Cover the plate with adhesive plastic and incubate for 2 hours at room temperature.
d. Remove the content in the wells and wash them 3X with 200 μL PBS buffer for 5 minutes each time.
Flick the plate and pat the plate as described in the coating step.
28. Competitive ELISA Procedure
5. Primary Antibody Incubation
a. Serially dilute the primary antibody of choice with blocking buffer. The optimal dilution should be
determined by a titration assay according to the antibody manufacturer.
b. Pipette 100 μL of each diluted antibody per well. Repeat in duplicate or triplicate for accuracy. The
negative control should be species- and isotype-matched as well as non-specific immunoglobulin diluted
in PBS buffer.
c. Cover the plate with adhesive plastic and incubate for 1 hour at 37°C (or 2 hours at room
temperature). These incubation times should be sufficient to receive a strong signal. However, if a weak
signal is observed, perform incubation overnight at 4°C for a stronger signal.
d. Remove the diluted antibody solution and wash the wells 3X with 200 μL PBS for 5 min each time.
29. Competitive ELISA Procedure
6. Secondary Antibody Incubation
a. Serially dilute the conjugated secondary antibody with blocking buffer immediately before use. The
optimal dilution should be determined by a titration assay according to the antibody manufacturer.
b. Pipette 100 μL of diluted secondary antibody solution to each well.
c. Cover the plate with adhesive plastic and incubate for 2 hours at room temperature.
d. Remove the content in the wells and wash them 3X with 200 μL PBS buffer for 5 min each time. Flick
the plate and pat the plate as described in the coating step.
30. Competitive ELISA Procedure
7. Substrate Preparation
Prepare the substrate solution immediately before use or bring the pre-made substrate to room
temperature. The two widely used enzymes for signal detection are horse radish peroxidase (HRP) and
alkaline phosphatase (AP), and their corresponding substrates, stopping solutions, detection absorbance
wavelengths and color developed are as follows:
a. The TMB substrate must be kept at 37°C for 30 min before use.
b. Hydrogen peroxide can also act as a substrate for HRP.
c. Sodium azide is an inhibitor of HRP. Do not include the azide in buffers or wash solutions if HRP-
labeled conjugate is used for detection.
31. Competitive ELISA Procedure
8. Signal Detection
a. Pipette 90 μL of substrate solution to the wells with the control, standard solutions and diluted
samples.
b. Incubate the plate at 37C in the dark. If TMB is used, shades of blue will be observed in the wells with
the most concentrated solutions. Other wells may show no obvious color.
c. Color should be developed in positive wells after 15 minutes. After sufficient color development,
pipette 100 μL of stopping solution to the wells (if necessary).
d. Read the absorbance (OD: Optical Density) of each well with a plate reader.
9. Data Analysis
a. Prepare a standard curve using the data produced from the diluted standard solutions. Use absorbance
on the Y-axis (linear) and concentration on the X-axis (log scale).
b. Competitive ELISA yields an inverse curve: Higher values of antigen in the samples yield a smaller
amount of color change.
c. Interpret the sample concentration from the standard curve.